Taylor, BJ orcid.org/0000-0001-5229-941X and Bowen, TS (2018) Respiratory Muscle Weakness in Patients with Heart Failure: Time to Make It a Standard Clinical Marker and a Need for Novel Therapeutic Interventions? Journal of Cardiac Failure, 24 (4). pp. 217-218. ISSN 1071-9164
Abstract
Dysfunction of the respiratory muscles (particularly the diaphragm) can compromise ventilation, pulmonary gas exchange, and oxygen delivery to the tissues. This is especially true for patients with heart failure (HF), where a loss in respiratory muscle strength and endurance capacity is common.¹‾⁴ Inspiratory muscle weakness in HF causes heightened breathlessness, exertional intolerance, and reduces health-related quality-of-life.⁵‾⁷ The clinical importance of respiratory muscle weakness has also been clearly demonstrated.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2018 Elsevier Inc. This is an author produced version of a paper published in Journal of Cardiac Failure. Uploaded in accordance with the publisher's self-archiving policy. |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Biomedical Sciences (Leeds) |
Depositing User: | Symplectic Publications |
Date Deposited: | 28 Mar 2018 11:43 |
Last Modified: | 27 Feb 2019 01:39 |
Status: | Published |
Publisher: | Elsevier |
Identification Number: | 10.1016/j.cardfail.2018.02.007 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:129039 |
Download
Filename: Taylor & Bowen Diaphragm Dysfunction J Card Fail Editorial (08 02 18).pdf
Licence: CC-BY-NC-ND 4.0